A new CAR-T cell that attacks an atypical solid cancer antigen
Carina has developed a broad-spectrum but highly targeted CAR-T cell (CNA1003). CNA1003 is targeted to a specific marker that has been found on most cancer cells but has little to no
Gel formulation to deliver clinically effective doses of CAR-T cells to solid tumours and resection sites
Our researchers are working on the production of a thermoresponsive gel formulation that can be used to deliver CAR-T cells to tumour and/or resection sites. Instead of the CAR-T cells
Genetic ‘homing signal’ to attract CAR-T cells to solid tumours
Our research team at the University of Adelaide, led by Professor Shaun McColl, is developing a way to enable chemokine receptor mediated CAR-T active migration to solid tumours. Chemokines are small